Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasm
Public ClinicalTrials.gov record NCT00234507. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II, Multi-centre, Randomised, Double-blind, Parallel Group, Placebo-controlled Study to Assess the Efficacy and Safety of a Single Administration, by Subcutaneous Injection, of Three Doses of Dysport (40 Units/Eye, 80 Units/Eye, and 120 Units/Eye) for the Treatment of Benign Essential Blepharospasm
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the effectiveness of 3 doses of Dysport® with placebo by assessing functional disability in blepharospasm.
Study identification
- NCT ID
- NCT00234507
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2003 (Type not available)
- Primary completion
- May 25, 2004 (Actual)
- Completion
- May 25, 2004 (Actual)
- Last update posted
- Jul 29, 2019
2003 – 2004
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner Health Research Institute | Phoenix | Arizona | 85006 | — |
| Neurological Institute | Phoenix | Arizona | 85013 | — |
| The Parkinson's and Movement Disorder Institute | Fountain Valley | California | 92708 | — |
| UCLA/Jules Stein Eye Institute | Los Angeles | California | 90095 | — |
| McKnight Brain Institute | Gainesville | Florida | 32610 | — |
| Plastic Eye Surgery Association | Pensacola | Florida | 32504 | — |
| Rush Presbyterian/St Luke's Medical Center | Chicago | Illinois | 60612 | — |
| Kellogg Eye Center | Ann Arbor | Michigan | 48105 | — |
| Columbia-Presbyterian Medical Center | New York | New York | 10032 | — |
| Duke University Medical Center | Durham | North Carolina | 27705 | — |
| Ophthlamic Surgeons and Consultants of Ohio, Inc | Columbus | Ohio | 43215 | — |
| Wills Eye Hospital | Philadelphia | Pennsylvania | 19107 | — |
| Parkinson's Disease Center and Movement Disorders Clinic | Houston | Texas | 77030 | — |
| Center for Facial Appearances | Salt Lake City | Utah | 84102 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00234507, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 29, 2019 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00234507 live on ClinicalTrials.gov.